The Beauty Health Company (NASDAQ:SKIN) Receives $2.46 Average PT from Brokerages

Shares of The Beauty Health Company (NASDAQ:SKIN - Get Free Report) have received a consensus recommendation of "Reduce" from the eleven ratings firms that are covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $2.46.

Several equities research analysts have commented on SKIN shares. Piper Sandler reaffirmed an "underweight" rating and set a $1.00 price objective (down from $1.50) on shares of Beauty Health in a report on Friday, August 9th. Canaccord Genuity Group decreased their target price on shares of Beauty Health from $2.00 to $1.25 and set a "hold" rating on the stock in a research report on Monday, August 12th. Finally, Stifel Nicolaus lowered their price objective on Beauty Health from $4.00 to $2.00 and set a "hold" rating for the company in a research report on Friday, July 26th.

Beauty Health Stock Up 0.6 %

Shares of SKIN stock traded up $0.01 on Thursday, reaching $1.68. 559,796 shares of the company were exchanged, compared to its average volume of 1,875,314. The company has a debt-to-equity ratio of 7.96, a current ratio of 6.49 and a quick ratio of 5.47. Beauty Health has a one year low of $0.91 and a one year high of $5.17. The company has a 50-day moving average of $1.58 and a 200-day moving average of $1.94. The company has a market cap of $208.35 million, a price-to-earnings ratio of -2.01 and a beta of 0.90.

Beauty Health (NASDAQ:SKIN - Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.05). The firm had revenue of $90.60 million during the quarter, compared to the consensus estimate of $98.46 million. Beauty Health had a negative return on equity of 4.57% and a negative net margin of 22.86%. Analysts anticipate that Beauty Health will post -0.2 earnings per share for the current year.

Insider Transactions at Beauty Health

In related news, Chairman Brent L. Saunders acquired 40,450 shares of the stock in a transaction dated Monday, August 12th. The stock was acquired at an average cost of $1.08 per share, with a total value of $43,686.00. Following the purchase, the chairman now directly owns 5,921,769 shares of the company's stock, valued at approximately $6,395,510.52. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 41.00% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of SKIN. Cohen Capital Management Inc. grew its holdings in Beauty Health by 344.1% in the third quarter. Cohen Capital Management Inc. now owns 572,848 shares of the company's stock worth $825,000 after purchasing an additional 443,859 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of Beauty Health in the 3rd quarter valued at about $37,000. Sanctuary Advisors LLC acquired a new position in Beauty Health in the second quarter valued at approximately $47,000. Susquehanna Fundamental Investments LLC purchased a new stake in Beauty Health during the second quarter worth $105,000. Finally, Federated Hermes Inc. boosted its stake in shares of Beauty Health by 349,616.0% during the 2nd quarter. Federated Hermes Inc. now owns 370,699 shares of the company's stock worth $712,000 after acquiring an additional 370,593 shares in the last quarter. 93.26% of the stock is currently owned by hedge funds and other institutional investors.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.